Vincent Medical Holdings Limited logo

Vincent Medical Holdings Limited

1612.HK

HKSEHealthcareMedical - Devices

Latest quote

HK$0.705

−HK$0.005 · -0.70%

Aug 24, 3:03 PM HKT

1612.HK company overview

Regular session · HKT · Market data may be delayed.

Company profile

Company website

Vincent Medical Holdings Limited is an investment holding company engaged in the comprehensive process of designing, manufacturing, marketing, and distributing medical devices. Its operations are bifurcated into two main business models: providing products for other companies (Original Equipment Manufacturing, or OEM) and selling goods under its own proprietary labels (Original Brand Manufacturing). For its OEM clientele, the company specializes in developing respiratory care products, disposable components for imaging contrast media power injectors, and a range of orthopedic and rehabilitation solutions. Its extensive respiratory portfolio encompasses humidification systems, nCPAP interface systems, dedicated respiratory care units, electronic air-oxygen blenders, and anesthesia systems. In the orthopedic and rehabilitation sector, Vincent Medical offers various adjustable braces engineered for post-injury or post-surgical support, protection, and recovery of musculoskeletal areas. The company also pioneers the development of robotic hand training devices. Under its own brand names, including Inspired Medical, Hand of Hope, and Hypnus, Vincent Medical Holdings Limited distributes its offerings across a wide international market. Key regions include the People's Republic of China, the United States, the Netherlands, Australia, and Japan. Established in 1997 and headquartered in Hung Hom, Hong Kong, the company functions as a subsidiary of Vincent Raya International Limited.

Industry
Medical - Devices
Sector
Healthcare
Headquarters
HK
CEO
Cheung Tai Choi
Listed since
Jul 13, 2016
Employees
1,468

Market position

52-week range

Current HK$0.705

Open
HK$0.705
Previous close
HK$0.71
Volume
0
0× average
Average volume
394.03K
Average daily volume
Market cap
458.32M HKD
Beta
0.75
Market reference 1
50-day average
HK$0.7295
-3.36% below average
200-day average
HK$0.8554
-17.58% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
461.94M HKD
P/E (TTM)
4.35×
P/B (TTM)
0.69×
P/S (TTM)
0.49×
EV / EBITDA
2.97×
Earnings yield
19.50%
Free cash flow yield
10.21%
Dividend yield
7.09%

Profitability & efficiency

Gross margin
35.10%
Operating margin
13.90%
Net margin
11.19%
Return on equity
15.70%
Return on assets
8.91%
Return on invested capital
12.69%

Financial health

Debt / equity
0.27×
Current ratio
1.96×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends39%24%9%-7%Gross margin, FY2021: 31.35%Gross margin, FY2022: 23.49%Gross margin, FY2023: 33.48%Gross margin, FY2024: 32.46%Gross margin, FY2025: 35.10%Operating margin, FY2021: 9.58%Operating margin, FY2022: -1.75%Operating margin, FY2023: 9.16%Operating margin, FY2024: 9.95%Operating margin, FY2025: 13.90%Net margin, FY2021: 7.80%Net margin, FY2022: -2.76%Net margin, FY2023: 7.98%Net margin, FY2024: 8.64%Net margin, FY2025: 11.19%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 31.35%. Gross margin FY2022 23.49%. Gross margin FY2023 33.48%. Gross margin FY2024 32.46%. Gross margin FY2025 35.10%. Operating margin FY2021 9.58%. Operating margin FY2022 -1.75%. Operating margin FY2023 9.16%. Operating margin FY2024 9.95%. Operating margin FY2025 13.90%. Net margin FY2021 7.80%. Net margin FY2022 -2.76%. Net margin FY2023 7.98%. Net margin FY2024 8.64%. Net margin FY2025 11.19%.

Income trends

Revenue

932.78M HKD+16.46%

Operating income

129.7M HKD+62.79%

Net income

104.38M HKD+50.91%
Income trends across reported periods1.03B HKD647.73M HKD267.66M HKD−112.42M HKDRevenue, FY2021: 777.72M HKDRevenue, FY2022: 629.24M HKDRevenue, FY2023: 717.97M HKDRevenue, FY2024: 800.96M HKDRevenue, FY2025: 932.78M HKDOperating income, FY2021: 74.49M HKDOperating income, FY2022: −11M HKDOperating income, FY2023: 65.78M HKDOperating income, FY2024: 79.67M HKDOperating income, FY2025: 129.7M HKDNet income, FY2021: 60.7M HKDNet income, FY2022: −17.4M HKDNet income, FY2023: 57.28M HKDNet income, FY2024: 69.17M HKDNet income, FY2025: 104.38M HKDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 777.72M HKD. Revenue FY2022 629.24M HKD. Revenue FY2023 717.97M HKD. Revenue FY2024 800.96M HKD. Revenue FY2025 932.78M HKD. Operating income FY2021 74.49M HKD. Operating income FY2022 −11M HKD. Operating income FY2023 65.78M HKD. Operating income FY2024 79.67M HKD. Operating income FY2025 129.7M HKD. Net income FY2021 60.7M HKD. Net income FY2022 −17.4M HKD. Net income FY2023 57.28M HKD. Net income FY2024 69.17M HKD. Net income FY2025 104.38M HKD.
Metric (HKD)FY2025FY2024FY2023FY2022FY2021
Revenue932.78M HKD800.96M HKD717.97M HKD629.24M HKD777.72M HKD
Cost of goods sold605.34M HKD540.97M HKD477.59M HKD481.41M HKD533.89M HKD
Gross profit327.44M HKD259.99M HKD240.39M HKD147.83M HKD243.83M HKD
Research and development48.74M HKD30.6M HKD36.06M HKD36.68M HKD39.25M HKD
Selling, general, and administrative148.61M HKD151.2M HKD139.08M HKD133.65M HKD125.42M HKD
Operating expenses197.75M HKD180.32M HKD174.61M HKD176.35M HKD164.38M HKD
Interest income1.3M HKD1.2M HKD697K HKD510K HKD382K HKD
Interest expense899K HKD1.36M HKD1.68M HKD2.85M HKD2.43M HKD
Depreciation and amortization21.32M HKD22.19M HKD38.33M HKD40.95M HKD40.06M HKD
Operating income129.7M HKD79.67M HKD65.78M HKD−11M HKD74.49M HKD
Net income104.38M HKD69.17M HKD57.28M HKD−17.4M HKD60.7M HKD

Company facts updated Aug 24, 2026.

Corporate actions

Annual dividends per share

Cash distributions grouped by calendar year; partial years are marked.

HK$0.041

2025 complete year-68.5% since 2021

2026 partial: HK$0.026

* Partial calendar year in the available dividend history.

Corporate action history

Dividend

Ex-dividend May 26, 2026

HK$0.026

Semi-Annual

Record May 28, 2026 · Payment Jun 18, 2026

Dividend

Ex-dividend Sep 2, 2025

HK$0.024

Semi-Annual

Record Sep 4, 2025 · Payment Sep 26, 2025

Dividend

Ex-dividend May 27, 2025

HK$0.017

Semi-Annual

Record May 28, 2025 · Payment Jun 20, 2025

Dividend

Ex-dividend Sep 3, 2024

HK$0.016

Semi-Annual

Record Sep 5, 2024 · Payment Sep 27, 2024

Dividend

Ex-dividend May 28, 2024

HK$0.015

Semi-Annual

Record May 30, 2024 · Payment Jun 21, 2024

Dividend

Ex-dividend Sep 5, 2023

HK$0.0125

Annual

Record Sep 6, 2023 · Payment Sep 29, 2023

1612.HK peers

Continue in GoAI

Research 1612.HK

research.disclaimer